Fig. 3From: Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancerThe comparison between plasma steady-state concentration of (Z)-endoxifen level and corresponding metabolic ratio. The metabolic ratio (MR) was estimated as (Z)-endoxifen plasma concentration divided by the sum of concentrations of the remaining measured compounds. The MR value of 0.0146 was delineated as the correlation coefficient with the level of 6Â ng/ml. The assigned CYP2D6 functional category, based on CYP2D6 genotype, is indicated in colorBack to article page